Updates from the Field

Updates from NFPRHA 

The National Family Planning and Reproductive Health Association Conference was held from March 5th to March 7th, 2017 in Washington, D. C. The conference drew a large crowd of attendees from across the U.S. ranging from family planning program providers, Title X grantee leaders and public health professionals enmeshed in the reproductive health programmatic environment. Pre-conference workshops took place on March 3rd to 5th on topics such as 340B University, discussing best practices, and honing revenue, marketing and grant writing skills. The full conference agenda covered important topics pertaining to the functioning of family planning programming, with a focus on upcoming policy and fiscal changes related to Medicaid, Title X and the potential repeal of the Affordable Care Act. The key takeaways of the conference were related to improving program sustainability, systems best practices, strategic planning and effective advocacy strategies. More information can be found at the NFPRHA website.  Next year’s conference will be held on March 18-21, 2018 in Washington, DC.


Important 340B Updates

The 340B Drug Discount Program is a U.S federal government program created in 1992 that requires drug manufacturers to provide outpatient drugs to eligible health care organizations or covered entities at significantly reduced prices. Eligible organizations that can participate in the program are listed in section 340B(a)(4)(A) of the Public Service Health Act (PHSA) and are enabled to purchase drugs at a discounted price. Eligible organizations must register for the program and receive a unique identification number to purchase and use the 340B discounted drugs. An organization participating in the program is referred to as a covered entity. Some covered entities within the program are: Federally Qualified Health Centers (FQHC), FQHC look-alikes, Title X Family Planning Clinics, Sexually Transmitted Disease Clinics and Ryan White HIV/AIDS Program Grantees.

Upcoming 340B open registration periods are April 1-15, July 1-15, and October 1-15. Programs apply to the Office of Pharmacy Affairs (OPA) and once approved, agencies receive a site-specific identification number to begin purchasing discounted drugs during the next quarter. Covered entities must recertify their eligibility every year and notify OPA if there is any change in eligibility. Instructions for the 2017 recertification are expected to be released shortly. Additional information about the 340B program may be accessed at the HRSA 340B home page.